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Abstract
Background: Combinatorial RNA interference (co-RNAi) is a valuable tool for highly effective gene suppression of
single and multiple-genes targets, and can be used to prevent the escape of mutation-prone transcripts. There are
currently three main approaches used to achieve co-RNAi in animal cells; multiple promoter/shRNA cassettes, long
hairpin RNAs (lhRNA) and miRNA-embedded shRNAs, however, the relative effectiveness of each is not known. The
current study directly compares the ability of each co-RNAi method to deliver pre-validated siRNA molecules to the
same gene targets.
Results: Double-shRNA expression vectors were generated for each co-RNAi platform and their ability to suppress
both single and double-gene reporter targets were compared. The most reliable and effective gene silencing was
achieved from the multiple promoter/shRNA approach, as this method induced additive suppression of single-gene
targets and equally effective knockdown of double-gene targets. Although both lhRNA and microRNA-embedded
strategies provided efficient gene knockdown, suppression levels were inconsistent and activity varied greatly for
different siRNAs tested. Furthermore, it appeared that not only the position of siRNAs within these multi-shRNA
constructs impacted upon silencing activity, but also local properties of each individual molecule. In addition, it
was also found that the insertion of up to five promoter/shRNA cassettes into a single construct did not negatively
affect the efficacy of each individual shRNA.
Conclusions: By directly comparing the ability of shRNAs delivered from different co-RNA platforms to initiate
knockdown of the same gene targets, we found that multiple U6/shRNA cassettes offered the most reliable and
predictable suppression of both single and multiple-gene targets. These results highlight some important strengths
and pitfalls of the currently used methods for multiple shRNA delivery, and provide valuable insights for the design
and application of reliable co-RNAi.
Background
Since the first application of DNA-delivered RNA inter-
ference (RNAi), the expression of short hairpin RNAs
(shRNAs) for targeted gene silencing has become a
benchmark technology. Using plasmid and viral vectoring
systems, the transcription of double stranded RNA pre-
cursors that are processed by the RNAi pathway has lead
to potent gene-specific knockdown. Importantly, such
strategies can permit the long-term delivery of shRNAs
to overcome the limitation of transient suppression by
small interfering RNAs (siRNAs). Building upon the early
experimental success of expressed shRNAs, the delivery
of multiple RNAi effectors, known as combinatorial
RNAi (co-RNAi), can offer considerable advantages over
the use of single molecule knockdown strategies
[reviewed in 1, 2]. Co-RNAi is particularly important for
evolving targets that require long-term treatment such as
highly mutable RNA viruses like human immunodefi-
ciency virus (HIV) and hepatitis C virus (HCV). Recent
studies have shown that the replication of these viruses
can be suppressed for periods as long as 75 days by the
expression of two of more shRNAs simultaneously [3-5].
In addition, the prospect of increased levels of gene silen-
cing and for multiple-gene targeting is also extremely
important for many other transcripts that are not parti-
cularly susceptible to spontaneous mutation such as host
genes and DNA viruses.
There are currently three main methods to achieve co-
RNAi in animal cells; multiple promoter/shRNA cassettes,
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long hairpin RNAs (lhRNA) and microRNA-embedded
shRNAs. The expression of multiple shRNAs from a single
construct encoding several separate promoter/shRNA cas-
settes offers the potential for relatively straightforward vec-
tor construction as previously validated RNAi cassettes
can be simply assembled as tandem repeats. Recent studies
have included the use of shRNA cassettes in combinations
of two [6], three [3,7,8], four [4,9,10], six [11,12], and in
one study a cloning strategy for the production of up to
seven was described but not validated [13]. Results consis-
tently show that such approaches provide an additive
effect on single and multiple-gene knockdown on a variety
of host and viral gene targets. Although in one study, indi-
vidual shRNAs were transcribed at much lower levels
when expressed from a 4 cassette construct compared to
single copy vectors [4].
The use of lhRNA or extended shRNAs (e-shRNAs)
represent a likely progression from single site targeting
as long dsRNA are naturally processed as part of the
RNAi pathway, and such molecules have been shown
not to induce interferon mediated responses [14-16]. A
number of recent studies have successfully utilised this
approach to target and suppress HIV replication
[5,15,17-21] and as a result, the parameters that deter-
mine efficient processing have been well defined. In par-
ticular, the effect of varying siRNA stem length and
positioning, spacing between siRNAs stems, and the
relative abundance of processed molecules have been
tested [19,20]. Despite these advances, siRNAs have
been produced from lhRNA precursors in a gradient
with the most abundant and active being at the end dis-
tal from the loop, resulting in reduced silencing for the
second, third and fourth siRNAs [5,19-21].
The insertion of shRNA sequences into naturally
occurring microRNA (miRNA) precursor sequences
represents a potentially favourable strategy as effector
molecules should be processed and exported by the
same cellular pathways as endogenous miRNAs. More-
over, it has been found that miRNA mimic shRNAs can
abolish competition of siRNAs and shRNAs for trans-
port and incorporation into RISC [22]. The insertion of
an effective shRNA into the miR-30 pre-miRNA back-
bone sequence resulted in enhanced activity [23] and by
embedding shRNAs in repeated miR-30 flanking
sequences up to three shRNAs were transcribed from
single constructs [24-27]. In addition, the BIC transcript
which encodes miR-155, was modified to express multi-
ple shRNAs [28] and a commercial vector featuring
miR-155 flanking sequences and an shRNA cloning site
has been widely used for shRNA delivery. The potential
for multiple shRNA expression by modifying naturally
occurring polycistronic miRNA clusters have also been
shown using an endogenous human miRNA cluster [29]
and chicken miRNA cluster [30].
Previous studies have clearly demonstrated that each
co-RNAi strategy can be used to achieve highly effective
gene suppression. However, these experiments generally
focus on the use of one chosen co-RNAi approach,
often involving substantial optimisation of that system.
To provide an overall picture of the strengths and weak-
nesses of each method of co-RNAi, we took a set of
active siRNAs and delivered them using validated and
proven expression systems without extensive method-
specific optimisation. By directly comparing the ability
of these shRNAs to initiate knockdown of the same
gene targets, this study provides practical information
for researchers looking to express multiple validated
siRNA sequences using an existing co-RNAi platform.
Methods
shRNA and lhRNA plasmids
All siRNA and shRNA sequences and their target repor-
ter plasmids used in this study are listed in Table 1, and
sequences of DNA oligonucleotides used to construct
shRNA and lhRNA vectors are listed in Additional File
1. siRNAs were designed and synthesized by Eurogentec.
Based on equivalent siRNA stem sequences, shRNAs
and lhRNAs were constructed using annealed com-
plementary oligonucleotides inserted into the BstBI
and AscI sites of pchU6-3-ClaI vector as previously
described [31]. This vector encodes the chicken U6-3
promoter inserted into the pGEM-T Easy cloning vector
(Promega) and is a sequence that has been shown to
transcribe shRNAs to similar levels as other chicken U6
promoters and the mouse U6 promoter (Wise et al.,
2007; Kudo and Sutou, 2005). All 19-nt shRNAs used
Table 1 siRNA and shRNA sequences and their reporter targets used in this study
siRNA shRNA Sequence (5’-3’) Reporter Target gene (Ref)
si-1a sh-1a GCACAUUUGUCGAGCUUAA psi-CHK-1 MDV gB [31]
si-1b sh-1b GGUUGGACAUGUACAAUAU psi-CHK-1 MDV gB [31]
si-2 sh-2 GAGUUAUGCUGAUAUGAAU psi-CHK-2 MDV UL29 [31]
si-3 sh-3 GGAGUUCACUGUAUCGUAC psi-CHK-3 MDV ncRNA (unpublished data)
- sh-4 GCUGGACUCCUUCAUCAAC psi-CHK-4 Renilla luciferase (unpublished data)
- sh-5 CAGCCAAUCACAUCCAUCAAA psi-CHK-5 IBDV VP2 [47]
si-NS sh-NS UUCUCCGAACGUGUCACGU - -
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the miR-30 loop sequence (5’-CTGTGAAGCCACA-
GATGGG-3’), and lhRNAs were designed based on pre-
viously optimised lhRNAs [19] and used the loop
sequence (5’-UUCAAGAGA-3’) unless otherwise stated.
All shRNAs and lhRNAs encoded a pol III termination
sequence consisting of six thymidine residues. To con-
struct the dual-U6/shRNA plasmids and the plasmids
featuring up to five consecutive U6/shRNA cassettes,
two backbone primer sequences were used: forward
primer (chU6-F1: 5’-CCGCGGGAATTCGATTGACAA-
CAC-3’) and reverse primer (chU6-R5: 5’-CTTGAA-
TTCATCGATGGGCGCG-3’), with various restriction
sites added to each for different cloning steps. To con-
struct the dual-U6/shRNA plasmids, shRNAs sh-1a, sh-
1b and sh-2 were first cloned into pchU6-ClaI. Then,
using chU6-F1 with an introduced SpeI site, and chU6-
R5 with an introduced SpeI site, each cassette was
amplified by PCR, digested with SpeI and inserted into
the appropriate U6/shRNA plasmid also digested with
SpeI. Plasmids featuring up to five consecutive U6/
shRNA cassettes were cloned using a series of PCR and
ligation steps (Additional File 2, Tables S1 and S2).
Briefly, to construct shRNAx3, the U6/shRNA-3 cassette
was amplified using chU6-F1 with introduced SbfI site
and chU6-R5 with introduced SalI and NdeI sites,
digested with SbfI and NdeI and ligated into dU6/F1a-F2
digested with the same enzymes. To construct shRNAx4,
the U6/shRNA-4 cassette was amplified using chU6-F1
with introduced SalI site and chU6-R5 with an intro-
duced MluI site, digested with SalI and MluI, and ligated
into shRNAx3 digested with the same enzymes. To con-
struct shRNAx5, the U6/shRNA-5 cassette was amplified
using chU6-F1 with an introduced MluI site and chU6-
R5 with an introduced NsiI site, digested with MluI and
NsiI, and ligated into U6-shRNAx4 digested with the
same enzymes. All plasmid and retroviral vectors used in
this study were confirmed by DNA sequencing.
miRNA-embedded shRNA plasmids
Sequences of DNA oligonucleotides used to construct
the miRNA-embedded shRNA plasmids are listed in
Additional File 1, Table S3. Vectors were constructed
using the pRFPRNAi system as described previously
[30]. The original 19-nt siRNA sequences were extended
by 3-nt (22-nt stems) and featured an altered residue at
the 5’ base of each passenger strand to mimic the miR-
30 structure (Figure 1). Briefly, hairpins for insertion
into position 1 of pRFPRNAi were generated by PCR
using gene-specific oligonucleotides along with the gen-
eric flanking oligonucleotides UHP1F+R. The resulting
fragments were digested with NheI and MluI and ligated
into pRFPRNAiC digested with the same enzymes. Hair-
pins for insertion into position 2 were then generated
by PCR using gene-specific oligonucleotides and the
generic flanking oligonucleotides UHP2F+R. These frag-
ments were digested with MluI and SphI and ligated
into pRFPRNAiC containing the relevant hairpin cloned
in position 1.
Retroviral vectors
shRNA, lhRNA and miRNA-embedded RNAi cassettes
were cloned into the retrovirus RCASBP-(A)-CN-EGFP
(with avian leukosis virus subgroup A envelope, a gener-
ous gift from Dr Jon Gilthorpe, Kings College London)
[32] using the unique NotI site. Prior to the insertion of
the dual-U6/shRNA cassettes into this vector, the
chicken U6-4 promoter was amplified from chicken
genomic DNA using U6-specific primers as previously
described [33] with an introduced SpeI site in the for-
ward primer (5’-GGACTAGTGAATTGTGGGACGG-
CGGAAG-3’), and reverse primer (5’-ATCGATG
GGGCGCGCCGTTTAAACACTAGTTCGAACCCC
AGTGTCTCTCGGACAGTA-3’) with introduced BstBI,
AscI and ClaI sites for the insertion of shRNA tem-
plates. Single U6/shRNA plasmids for the chicken U6-4
promoter were then generated for sh-1b and sh-2 using
the same method as described previously [31]. These
constructs were then digested with SpeI and ligated into
U6-sh1a also digested with SpeI. The entire single and
dual-U6/shRNA cassettes and U6/lhRNA cassettes were
then excised by digestion with NotI and inserted
into RCASBP-(A)-CN-EGFP also digested with NotI.
To insert the miRNA-embedded shRNA cassettes,
pRFPRNAi-specific primers were used to amplify the
U6/miRNA inserts using forward primer (5’-TCGACC-
TGCAGCCCAAGCTT-3’) and reverse primer (5’-ATA
AGAATGCGGCCGCGCAGCGGATCCATCGATAAA-
3’) which contained an introduced NotI site. Amplified
fragments were then digested with NotI and inserted
into RCASBP-(A)-CN-EGFP that had also been digested
with NotI. All U6/RNAi cassettes inserted into
RCASBP-(A)-CNEGFP were in the reverse orientation.
Reporter plasmids
All reporter plasmids were generated using psiCHECK™-
2 (Promega) by PCR amplifying target sequences and
inserting these into the NotI and XhoI site downstream
of the Renilla luciferase gene (Figure 2A). The following
primer pairs and template DNAs were used: psi-CHK-1;
forward primer (5’-CCGCTCGAGTCCAAATCGCAT-
CATATTAGGA-3’) and reverse primer (5’-ATAGTT-
TAGCGGCCGCGCAAAATTTCCCGATCTTCTAG-3’),
psi-CHK-2; forward primer (5’-CCGCTCGAGCGCTTT-
TACTCCTGCGGCAGAAACTA-3’) and reverse primer
(5’-ATAGTTTAGCGGCCGCGACAGCAACCAATG
CCGAAATT-3’), psi-CHK-3; forward primer (5’-
CCGCTCGAGGAGCGGTTTTTCTCCTTCC-3’) and
reverse primer (5’-ATAGTTTAGCGGCCGCGAACG
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AAGGGTTCCGATACA-3’) were all amplified using
MDV BAC pRB-1B5 DNA [34]. For psi-CHK-5, the
infectious bursal disease virus (IBDV) VP2 gene cloned
into pCI-Neo (Promega), named pCI-VP2, was a gener-
ous gift from Heba Mahgoub, Institute for Animal
Health (Unpublished data), and was digested with NotI
and XhoI and inserted into psiCHECK™-2 digested with
the same enzymes. The psi-CHK-4 plasmid used was
unmodified psiCHECK™-2, as Renilla luciferase was tar-
geted by sh-4 (Table 1).
Cells and transfections
The DF-1 cell line derived from line 0 chicken embryo-
nic fibroblasts [35] were maintained in Dulbecco’s modi-
fied Eagles medium (DMEM) containing 10% foetal calf
serum with 10% CO2 at 39°C and used for reporter
assays and for retrovirus growth. Plasmid DNA and
siRNA transfections were carried out in 96-well plates
using 125 ng of each plasmid DNA or 50 nM siRNAs
using Lipofectamine 2000 (Invitrogen) following the
manufacturer’s instructions. For retrovirus growth, 2 μg
of RCAS-U6/shRNA plasmid DNA was transfected into
DF-1 in 6-well plates and passaged 6 days post-transfec-
tion into T75 flasks for RNA isolation or 96-well plates
for reporter plasmid transfection.
Reporter assays
The reporter vector psiCHECK™-2 carrying the sequences
of the various shRNA target transcripts were assayed for
luciferase expression using the Dual Glo Luciferase Assay
System (Promega) following the manufacturer’s instruc-
tions. The relative expression of target specific Renilla
Figure 1 Schematic representation of the strategies used for combinatorial RNAi. Each method of co-RNAi results in the transcription of
dsRNA precursor molecules that encode the siRNA stem (red or blue), a loop sequence and a passenger strand, that are processed into active
siRNAs. The top panel shows a multiple promoter/shRNA construct that encodes dual U6 promoters to express two separate shRNAs
simultaneously. The middle panel shows a long hairpin RNA (lhRNA) construct that uses a single U6 promoter to express an extended shRNA
that encodes two separate siRNA stems. The bottom panel shows a miRNA-embedded construct that uses a single U6 promoter to express a
miRNA cluster that features two introduced shRNAs that mimic naturally expressed miRNAs.
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luciferase was determined by taking the normalised levels
compared to background Firefly luciferase for each sam-
ple transfected in four replicates ± standard error and is
representative of at least two independent experiments.
Northern blotting
Total RNA was extracted from cultured DF-1 cells
infected with retroviral vectors using TRIzol reagent (Invi-
trogen) according to standard methods described by the
manufacturer. Samples of 30 μg total RNA were resolved
using a 15% polyacrylamide-1 × Tris-borate-EDTA-8 M
urea gel and blotted to a GeneScreen Plus membrane
(Perkin-Elmer). DNA oligonucleotides with sequences
complementary to the shRNAs were end labelled with
[g-32P] ATP (Amersham) and T4 polynucleotide kinase
(New England Biolabs) to generate high-specific-activity
probes. Hybridization, washing, and autoradiography were
carried out as previously described [36].
Figure 2 shRNA vectors and their reporter targets, and the efficacy of siRNAs compared to equivalent molecules expressed as
shRNAs. (A) Schematic representation of the single U6/shRNA constructs and their target Luciferase reporter vectors used in this study. A total
of 6 different shRNA sequences were cloned downstream of the U6 promoter. Using psi-CHECK-2, five different reporter vectors were
constructed that encode Firefly luciferase and each of the shRNA target sequences fused to Renilla luciferase (except psi-CHK-4 as Renilla
luciferase was the shRNA target sequence). For each reporter vector, the shRNA that targets each is indicated. (B) Normalised ratios of the Renilla:
Firefly luciferase activity when DF-1 cells were co-transfected with the indicated reporter plasmids and either 50 nM of siRNAs or 125 ng of
shRNA plasmid DNA. Values for siRNAs are shown as percentages of the negative control siRNA (si-NS), and values for shRNAs are shown as
percentages of the negative control shRNA (sh-NS), as the mean of 4 replicates ± standard error.
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Statistical Analysis
Experimental data was analysed for statistical signifi-
cance using two-tailed unpaired T-tests, where P
values of less than 0.05 were considered significant.
Statistical analysis was carried out using GraphPad
Prism version 5.0b.
Results
Efficacy of single and double-gene targeting U6
expressed shRNAs
The simultaneous expression of several RNAi effectors
can be achieved using various approaches, including
multiple promoter/shRNA cassettes, long hairpin RNAs
(lhRNA) and microRNA-embedded shRNAs (Figure 1).
For the direct comparison of expressed shRNA from
each co-RNAi platform, it was important to first test
that the set of already validated siRNA sequences could
be expressed as standard 19-nt shRNAs to achieve simi-
lar levels of gene knockdown. The sequences of all siR-
NAs and their target genes are detailed in Table 1, and
all shRNAs and their target reporter plasmids are shown
in Figure 2A. Co-transfection of reporter plasmids with
either siRNAs or their equivalent shRNAs showed that
for each of the four different molecules tested the effi-
cacy of the expressed shRNA was very similar to its
equivalent siRNA (Figure 2B), indicating that they were
appropriate for use in the comparison of co-RNAi
methods.
To test if single-gene targeting dual-U6 promoter con-
structs could provide additive gene suppression and to
assess the impact of promoter orientation, the activity of
plasmids with one U6/shRNA cassette in a forward
orientation and a second cassette in either orientation
were compared (Figure 3A). Co-transfection of these
plasmids along with psi-CHK-1 showed that both dual-
U6/shRNA vectors induced significantly greater reporter
knockdown compared to the corresponding single
shRNA vectors U6/sh-1a and U6/sh-1b (P < 0.05). In
addition, since both dual-U6/shRNA were equally effec-
tive, these data suggest that the orientation of the sec-
ond promoter does not considerably affect shRNA
transcription. To assess if the location of each promoter
sequence effected shRNA transcription, we then con-
structed double-gene targeting dual-U6/shRNA expres-
sion vectors. These contained two promoters in the
forward orientation and encoded shRNAs targeting dif-
ferent genes in either the first or second positions (Fig-
ure 3B). Co-transfection of these plasmids with either
psi-CHK-1 or psi-CHK-2 showed that both were able to
suppress their corresponding targets similarly to equiva-
lent single shRNA constructs and were equally effective
in either of the two promoter positions. These data
suggested that promoter location does not have an
obvious impact on transcription efficiency and that each
promoter can transcribe shRNA as effectively when pre-
sent in plasmids with either one or two copies.
Efficacy of single and double-gene targeting U6
expressed long hairpin RNAs
Several parameters that determine effective processing
of lhRNAs have been tested and have resulted in effec-
tive gene silencing and inhibition of HIV-1 replication
[5,19,20]. Based on the study by Poi Liu et al., (2007) we
Figure 3 Inhibition of Luciferase reporters by dual-U6
promoter delivered shRNAs. (A) Schematic representation of the
single-gene targeting dual-U6/shRNA plasmids, and normalised
ratios of the Renilla:Firefly luciferase activity when DF-1 cells were
co-transfected with psi-CHK-1 and the indicated RNAi plasmids
(asterisks indicate P < 0.05 compared to equivalent single shRNAs,
n = 4, two-tailed unpaired T-tests). (B) Schematic representation of
the double-gene targeting dual-U6/shRNA plasmids, and normalised
ratios of the Renilla:Firefly luciferase activity when DF-1 cells were
co-transfected with either psi-CHK-1 or psi-CHK-2 and the indicated
RNAi plasmids. The mock control refers to a reporter plasmid alone
transfection. Values are shown as percentages of the non-targeting
shRNA as the mean of 4 replicates ± standard error.
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chose to use the lhRNA organisation strategy that
appeared to give the most reliable gene suppression.
This consisted of 19-nt siRNA stems separated by a
3-nt spacer region, and each strand separated by the
commonly used shRNA loop sequence (5’-UUCAA-
GAGA-3’) that was originally tested by Brummelkamp
et al. (2002). To see if an lhRNA could produce
enhanced single-target gene suppression, two constructs
were generated that encoded sh-1a and sh-1b in either
the first or second positions (Figure 4A). Co-transfection
of these constructs along with psi-CHK-1 showed that
both lhRNA plasmids were efficient at suppressing
Renilla expression, although this was only equal to the
single U6/shRNA constructs. Despite these lhRNAs not
providing an additive affect, these data further confirm
that this lhRNA configuration is effective and robust, as
no optimisation of shRNA or spacer sequences was
required. It has been shown that shRNA efficacy can be
considerably improved by the use of naturally occurring
loop sequences, such as the miR-30 loop, instead of
arbitrary sequences [23,31]. To test this, we inserted the
miR-30 loop sequence (5’-CTGTGAAGCCACA-
GATGGG-3’) into the most effective lhRNA construct,
U6/lh-1a-1b. It was found that this did not increase the
activity of the lhRNA as the level of reporter suppres-
sion was similar to the original construct (Figure 4B).
To test if two separate genes could be targeted using
lhRNAs and to further analyse the effect of siRNA loca-
tion, we constructed vectors that encoded the sh-1a and
sh-2 sequences in either of the two positions (Figure
4C). Co-transfection of these two plasmids along with
either psi-CHK-1 or psi-CHK-2 resulted in effective
knockdown of Renilla for both reporters, although the
suppression by sh-2 when in the second position
was considerably reduced. The most efficient lhRNA,
U6/lh-2-1a, was less effective compared to the single
shRNA controls, but reduced both target genes by
nearly 80%. Given that sh-1a was most efficient in the
first position, and sh-2 was most efficient in the second
position, these data suggest that siRNA location in the
lhRNA does not determine efficacy alone, but the indivi-
dual properties of each siRNA is also an important
determinant.
Efficacy of single and double-gene targeting U6-
expressed miRNA-embedded shRNAs
To validate the activity of shRNAs embedded into a
miRNA context, dual shRNA expression constructs
were generated using the vector pRFPRNAi [30]. This
plasmid features sequences from the chicken miRNA
operon encoding miR-106a, 18b, 20b, 19b-2, 92-2 and
363 [37] modified to contain two consecutive shRNA
insertion sites. pRFPRNAi uses the chicken U6-3 pro-
moter to transcribe shRNAs modified to mimic miR-30
Figure 4 Inhibition of Luciferase reporters by long hairpin
RNAs. (A) Schematic representation the single-gene targeting lhRNA
plasmids, and normalised ratios of the Renilla:Firefly luciferase
activity when DF-1 cells were co-transfected with psi-CHK-1 and the
indicated RNAi plasmids. (B) Normalised ratios of the Renilla:Firefly
luciferase activity when DF-1 cells were co-transfected with psi-CHK-
1 and an lhRNA featuring a miR-30 loop sequence (U6/lh-miR-1a-
1b), or the indicated RNAi plasmids. (C) Schematic representation
the double-gene targeting lhRNA plasmids, and normalised ratios of
the Renilla:Firefly luciferase activity when DF-1 cells were co-
transfected with either psi-CHK-1 or psi-CHK-2 and the indicated
RNAi plasmids. The mock control refers to a reporter plasmid alone
transfection. Values are shown as percentages of the non-targeting
shRNA as the mean of 4 replicates ± standard error.
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and can result in effective gene suppression of both
reporter and endogenous gene targets [38-40]. We first
compared the activity of two pRFPRNAi vectors to tar-
get a single transcript by the expression off sh-1a and
sh-1b from each of the two miRNA loci. It was found
that both constructs provided knockdown to a level that
was at least equal to the single shRNA vector U6/sh-1a
(Figure 5A). The ability of this vector to deliver shRNAs
to target two separate transcripts was then determined
by inserting sh-1a and sh-2 in each of the two miRNA
loci. Although both vectors effectively suppressed the
two reporters simultaneously, p1-miR-2/p2-miR-1a was
the most effective at reducing both targets (Figure 5B).
Interestingly, these data show that the activity of sh-2
was reduced when expressed as a miRNA, a finding that
was also seen when sh-2 was encoded as an lhRNA. In
addition, considering that sh-1a was most efficient in
position 2, and sh-2 was more effective in position 1, it
appeared that shRNA location alone did not determine
molecule efficacy. Overall, these data show that miRNA-
embedded shRNAs can effectively suppress gene expres-
sion for both single and double gene targets, although
the efficacy of sh-2 was somewhat reduced.
Comparison of co-RNAi methods by retroviral delivery
To determine which of the three co-RNAi methods
represents the most effective and robust strategy for
gene suppression, we directly compared the most effi-
cient single and double-gene knockdown vectors for
their ability to suppress reporter gene activity. To avoid
the inconsistencies associated with co-transfection of
RNAi and reporter plasmids, and to provide a back-
ground that is more applicable to experimental gene
knockdown studies, we inserted the most effective of
each dual RNAi cassette into the retroviral vector
RCASBP(A)-CN-EGFPm5. However, Considering that
the recombination and deletion of repeated U6
sequences in viral vectors has been seen before [4,41],
prior to insertion of the dual-U6 cassettes into RCAS,
we swapped the second U6 promoter of these constructs
with the chicken U6-4 promoter. It was found that sh-
1b and sh2 expressed from this promoter achieved a
similar level suppression to those transcribed by chU6-3
(data not shown), a finding that is consistent with others
[33,42].
Stable cell lines were produced by incubating trans-
fected DF-1 cells for 6 days until at least 95% of were
EGFP positive and were passaged into a larger vessel for
RNA isolation or into 96-well plates for transfection
with reporter plasmids. The expression of sh-1a was
examined by Northern blot hybridization using a probe
for sh-1a (Figure 6A). The positive control shRNA
(sh-1a) was heavily expressed and the levels of this
shRNA for the dual-U6/shRNA constructs (dU6-F1a-
F1b and dU6-F1a-F2) were similar. For the lhRNA con-
structs, there were dense bands higher in the blot indi-
cating high levels of unprocessed lhRNA precursors.
The relative levels of the shRNA produced as miRNA-
embedded transcripts were also at much lower levels
compared to those expressed as regular shRNAs. As
these bands were of the same size as the positive control
shRNAs, this suggested that although they were effec-
tively processed to shRNAs, they were less abundant. To
directly compare the efficacy of each method of co-
RNAi, each stable cell line was transfected with either
psi-CHK-1 or psi-CHK-2 and relative levels of knock-
down were determined by luciferase assay (Figure 6B). It
was found that suppression was generally at much lower
levels than seen by co-transfection, even for the single
shRNA positive controls. This may be explained by the
presence of more copies of the expression constructs in
the plasmid transfected cells compared to the viral
transduced cells. Cells transduced with the dual U6/
shRNA constructs were effective to a level similar to the
single shRNA controls, the lhRNAs provided only very
modest knockdown, and the miRNA-embedded shRNAs
were somewhat varied. Although these data were consis-
tent with the bands visualised by Northern blotting, it
was surprising to see such a decrease in knockdown effi-
ciency compared to that achieved by the co-transfection
of plasmid vectors. Overall, the dual U6-expressed
shRNAs targeting both single and double gene combina-
tions provided the most consistent knockdown, although
they were unable to improve upon the single shRNA
constructs alone.
Analysis of the limitations of co-RNAi
The limitations of lhRNA-mediated RNAi are evident
both in previous studies and by the data presented in
the current study. It has been shown that the siRNA
activity diminishes with distance from the lhRNA base
[19-21], and we showed that the efficacy of the three
siRNA tested varied depending on the sequence and
location within the lhRNA (Figure 4A and 4C). Taken
together, it appears that although the use of lhRNA
can result in highly effective gene knockdown, this
might require detailed optimisation for a given set of
sequences, rather than simply linking effective siRNAs
sequences together.
To further investigate the versatility of the miRNA-
embedded co-RNAi approach, we tested the effect of
having various siRNA sequences in either of the 2
miRNA loci of pRFPRNAi. To test if the shRNAs
expressed from pRFPRNAi were effective in the absence
of the surrounding miRNA sequences, we constructed
“miRNA mimic” shRNAs based on the miR-30 structure
that encoded siRNA stems extended by 3-nt and a sin-
gle mismatched nucleotide at the 5’ end (Figure 7A).
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Figure 5 Inhibition of Luciferase reporters by miRNA-embedded shRNAs. (A) Schematic representation the single-gene targeting miRNA-
embedded shRNA plasmids, and normalised ratios of the Renilla:Firefly luciferase activity when DF-1 cells were co-transfected with psi-CHK-1
and the indicated RNAi plasmids. (B) Schematic representation the double gene targeting miRNA-embedded shRNA plasmids, and normalised
ratios of the Renilla:Firefly luciferase activity when DF-1 cells were co-transfected with either psi-CHK-1 or psi-CHK-2 and the indicated RNAi
plasmids. The mock control refers to a reporter plasmid alone transfection. Values are shown as percentages of the non-targeting shRNA as the
mean of 4 replicates ± standard error.
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Co-transfection of RNAi plasmids along with appropri-
ate reporter plasmids showed that the sh-1a and sh-1b
22-nt miRNA mimic shRNAs were significantly more
effective than their equivalent 19-nt regular shRNAs
(P < 0.05), whereas there appeared to be no change
in the activity of the sh-2 molecule (Figure 7A). In
contrast, individual shRNA efficacy varied greatly when
expressed from each of the two miRNA loci. In particu-
lar, sh-1a showed increased activity in position 2, sh-1b
showed reduced activity in position 1 and was comple-
tely inert in position 2, and sh-2 showed a decrease in
activity for both loci. Overall, it appeared that individual
Figure 6 Direct comparison of the three co-RNAi strategies by retroviral delivery. (A) Northern blot analysis of total RNA extracted from
DF-1 cells stably expressing single and double-gene targeting co-RNAi cassettes probed for sh-1a. (B) Normalised ratios of the Renilla:Firefly
luciferase activity when DF-1 cells stably expressing single and double gene targeting co-RNAi cassettes were transfected with either psi-CHK-1
or psi-CHK-2. Values are shown as percentages of the negative control shRNA (sh-NS), as the mean of 4 replicates ± standard error.
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Figure 7 Testing the limitations of miRNA-embedded shRNAs and multiple U6/shRNA cassettes by inhibition of Luciferase reporters.
(A) The left panel shows a schematic representation of the predicted transcription products of a standard 19-nt shRNA (shRNA-19nt), a miR-30
mimic shRNA with a 3-nt extended stem and mismatched bp in the passenger strand (shRNA-22nt), a miRNA mimic shRNA from the first locus
in pRFPRNAi (p1-miRNA), and a miRNA mimic shRNA from the second locus in pRFPRNAi (p2-miRNA). For each the siRNA stem is shown in red.
The right panel shows normalised ratios of the Renilla:Firefly luciferase activity when DF-1 cells were co-transfected with the indicated RNAi
plasmids and their target Luciferase reporter plasmids (asterisks indicate P < 0.05 compared to equivalent 19-nt regular shRNAs, n = 4, two-tailed
unpaired T-tests). (B) The top panel shows a schematic representation of the multiple U6/shRNA constructs featuring 1, 2, 3, 4 or 5 individual U6/
shRNA cassettes. The bottom panel shows normalised ratios of the Renilla:Firefly luciferase activity when DF-1 cells were co-transfected with the
indicated RNAi plasmids and each of the luciferase reporter plasmids. The +VE control shRNAs used for each reporter were: sh-1a for psi-CHK-1,
sh-2 for psi-CHK-2, sh-3 for psi-CHK-3, sh-4 for psi-CHK-4 and sh-5 for psi-CHK-5. Values are shown as percentages of the negative control shRNA
(sh-NS), as the mean of 4 replicates ± standard error.
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shRNA efficacy could be increased by mimicking the
miR-30 structure, but activity of the shRNAs expressed
from pRFPRNAi varied greatly depending both on
shRNA sequence and location.
In the current study, it was shown that cassette loca-
tion and orientation in the dual-U6/shRNA vectors did
not markedly affect shRNA activity. However, a previous
report found that the abundance of individual shRNAs
expressed from similar constructs decreased with when
four shRNA cassettes were present [4], although the
effect of this on gene suppression was not tested. To
further explore these observations, we generated a series
of vectors featuring increasing numbers of U6/shRNA
cassettes and tested their ability to induce reporter gene
knockdown (Figure 7B). A total of five U6/shRNA cas-
settes targeting five different reporter sequences were
developed, allowing for the analysis of individual shRNA
efficacy from vectors carrying 1, 2, 3, 4 or 5 separate
U6/shRNA cassettes. Co-transfection of the multiple
U6/shRNA plasmids along with appropriate reporter
vectors showed that all of these were able to suppress
gene expression at a rate similar to that of the positive
controls (single U6/shRNA) regardless of how many cas-
settes were present. In particular, the shRNAx5 vector
induced comparable levels of gene suppression to each
of the single U6/shRNA positive controls, except for
sh-4 however, which showed a 20% reduction in activity.
A reduction in activity was also evident for the
shRNAx3 vector when targeting the psi-CHK-3 reporter,
and the shRNAx5 when targeting the psi-CHK-4 repor-
ter, as both were slightly less effective compared to their
respective positive control shRNAs. Importantly how-
ever, reporters 1, 2 and 5 showed equally efficient
knockdown regardless of the number of shRNA cas-
settes present. Overall, these data suggest that vectors
encoding up to five U6 promoters can maintain very
high levels of individual gene silencing activities.
Discussion
Co-RNAi has been used to achieve potent gene silencing
of single and multiple-gene targets by means of a num-
ber of different techniques. Although all of these meth-
ods can result in efficient gene suppression, such studies
often involve the detailed optimisation of the chosen
system and experimental findings are not reported in
the context of the other delivery options. Since the
initial use of pol III expressed shRNAs in mammalian
cells [43,44] this strategy has become a standard techni-
que for single-target vector delivered RNAi and has
been the subject of extensive optimisation. More
recently, the analysis of key factors that determine
lhRNA and miRNA-embedded shRNA efficacy, has seen
both of these strategies achieve enhanced gene knock-
down. For lhRNAs this has included siRNA length and
spacing between siRNAs stems [19,20], and for miRNA-
embedded shRNAs the use various flanking sequences
and lengths [26,28], and the placement [29] of siRNAs
within miRNA sequences contexts has been tested.
Following the identification of effective siRNA mole-
cules for target genes of interest, the selection of a deliv-
ery strategy for co-RNAi presents several options, each
of which appear to offer reliable gene knockdown. To
determine which of these methods is the most effective,
predictable and robust, we took a set of active siRNAs
and directly compared their ability to suppress gene
expression when delivered by each co-RNAi platform.
Since the goal of this study was also to determine the
ease at which each technique could be applied to any
given set of siRNAs, we used standard 19-nt siRNAs
rather than molecules that have been specifically opti-
mised and selected for each individual expression sys-
tem. This study therefore analyses the adaptability of
standard siRNA sequences that would be generated by
publicly available algorithms or as custom designed siR-
NAs to be used in each of the delivery platforms
described. Prior to testing the siRNAs in the co-RNAi
vectors, the expression of these sequences as regular 19-
nt shRNAs resulted in equivalent gene suppression
(Figure 2B), illustrating that these particular siRNAs can
be effectively expressed as shRNAs without optimisation.
Initially, we analysed dual shRNA expression approaches
as previous experiments suggest that although using
three and four shRNA expression constructs can be
highly effective, these only slightly improve on the levels
of gene silencing seen by the dual systems [5,29]. In
addition, the levels of shRNA generated from multiple
promoter constructs diminished when numerous pro-
moters were used [4], and the second, third and fourth
siRNA in lhRNA constructs become increasingly less
effective the further they are away from the stem
[5,19,20]. Therefore, to keep the number of variables at
a minimum, this study initially involved the comparison
of multiple promoter/shRNA, lhRNAs and miRNA-
embedded shRNA vectors expressing only two siRNAs
targeting either single or double gene combinations.
Our data showed that both dual-U6/shRNA and
miRNA-embedded expression plasmids increased gene
suppression of single-gene targets compared to equiva-
lent to single shRNAs. In contrast, the single-gene tar-
geting lhRNAs only suppressed gene expression to levels
equivalent to the first siRNA, which is not surprising
considering the reported gradient-effect in which they
are produced. For the double-gene targeting plasmids,
both lhRNA and miRNA-embedded shRNAs were more
variable and showed slightly decreased gene knockdown
compared to the dual-U6/shRNA plasmids, which
performed equally well as single shRNAs. Using retro-
viral-delivered co-RNAi, each expression platform was
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directly compared showing that although the single-gene
targeting miRNA-embedded vector was reasonably effec-
tive, it was only the dual-U6/shRNA vectors that
achieved a similar level of both single and double repor-
ter gene knockdown to the control shRNAs. However,
considering that these vectors were not able to provide
enhanced gene knockdown (as seen in the co-transfec-
tions in Figure 3A), overall the dual-U6/shRNA con-
structs did not provide a substantial increase in activity
compared to single U6/shRNAs. The lack of activity of
the lhRNA retroviruses was explained by the appearance
of unprocessed RNA precursors by Northern blotting,
and the presence of faint bands for the miRNA-
embedded shRNAs was consistent with their low activity
in the reporter assays. These data showed that for this
set of siRNAs, despite using slightly optimised config-
urations for both lhRNA and miRNA-embedded
shRNA, that the dual-U6/shRNAs provided the most
effective and robust gene silencing.
By comparing the efficacy of different siRNA molecules
expressed as lhRNAs or miRNAs, it appeared that both
the location and individual properties of each siRNA
could affect silencing activity. Perhaps qualities such as
sequence and local structure of different molecules can
directly impact upon efficient processing and production
of siRNAs, possibly through changes in their thermody-
namic properties. For example, when expressed as an
lhRNA, sh-1a was most effective in the first position,
whereas sh-2 was more effectual in the second position.
Furthermore, when expressed as miRNA-embedded
shRNAs, sh-1a was most efficient in position 2, whereas
sh-2 which was most effective in position 1. To further
explore this, we examined the individual efficacy of three
different shRNAs expressed from each of the locations as
embedded-miRNAs and found enormous variation
ranging from increased to completely abolished activity.
This suggests that the individual sequence of each
shRNA can have a marked impact on the processing and
subsequent activity of shRNAs expresses from each loci
of this vector. Unlike lhRNAs and miRNA-embedded
shRNAs, U6-transcribed regular 19-nt shRNAs do not
appear to be affected by their surrounding sequences.
However, since reduced levels of individual shRNAs is
caused by increasing numbers of RNAi cassettes [4], we
tested if this reduction translated to a functional effect on
levels of gene knockdown. Overall, the expression of up
to 5 separate shRNAs from a single construct resulted in
a small decrease in activity for only one of the five tar-
gets, suggesting that although each shRNA might be less
abundant, there was still a sufficient amount to reduce
gene expression to similar levels. One concern over the
use of multiple promoters for co-RNAi, and indeed
strong promoters such as U6 in general, is the saturation
of the RNAi machinery resulting in impaired processing
of endogenous miRNAs [22,45,46]. These data would
suggest however, that since pol III transcribes individual
shRNAs from multiple promoter constructs at lower
levels than single promoter cassettes, the overall levels of
shRNAs in these cells may be similar to those containing
single cassettes and may therefore not further add to this
concern.
Conclusions
The parameters that determine shRNA efficacy are now
very well defined; the same cannot be said however, for
constructs that express multiple RNAi effectors. By
directly comparing the same set of siRNAs expressed
using three separate methods of co-RNAi we have identi-
fied some of the strengths and pitfalls associated with
each technique. Overall, the use of multiple U6/shRNA
cassettes offered the most reliable and predictable gene
knockdown of both single and multiple-gene targets, an
effect that was not inhibited by having up to five separate
shRNA cassettes. It remains to be seen however, the
impact of having multiple pol III promoters on cellular
RNAi machinery, endogenous miRNA processing and
the expression of native pol III transcripts. In such a case,
the use of RNAi effectors that resemble naturally occur-
ring molecules such as miRNAs and long dsRNAs, may
best avoid unwanted cellular effects, especially consider-
ing that miRNA mimic shRNAs can abolish competition
of siRNAs and shRNAs for transport and incorporation
into RISC [22]. In any case, this study for the first time
directly compares three methods for the delivery of mul-
tiple shRNAs and provides valuable insights for the
design and application of reliable combinatorial RNAi.
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steps, consecutive U6/shRNA cassettes were inserted in a step-wise
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dU6-F1a-F2. PCR fragments encoded the U6 promoter, an shRNA
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